Isolation of CD34(+) cells with the Amgen cell selection system provides T, NK and tumor cell depletion of peripheral blood stem cells from breast cancer patients.

被引:0
|
作者
Symann, M
Guillaume, T
Salmon, M
Briddell, R
Zilm, K
Canon, JL
Andre, M
Jurdan, M
Johnsen, H
Richel, D
Myltenyi, S
Ewen, C
McNiece, I
机构
[1] HOP ST LUC,BRUSSELS,BELGIUM
[2] HERLEV HOSP,COPENHAGEN,DENMARK
[3] MST,ENSCHEDE,NETHERLANDS
[4] AMGEN INC,THOUSAND OAKS,CA
[5] AMCELL,SUNNYVALE,CA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:254 / 254
页数:1
相关论文
共 50 条
  • [41] Positive selection of CD34(+) cells from cryopreserved peripheral blood stem cells after thawing: Technical aspects and clinical use
    Bohbot, A
    Lioure, B
    Faradji, A
    Schmitt, M
    Cuillerot, JM
    Laplace, A
    Oberling, F
    BONE MARROW TRANSPLANTATION, 1996, 17 (02) : 259 - 264
  • [42] Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system
    Rowley, SD
    Loken, M
    Radich, J
    Kunkle, LA
    Mills, BJ
    Gooley, T
    Holmberg, L
    McSweeney, P
    Beach, K
    MacLeod, B
    Appelbaum, F
    Bensinger, WI
    BONE MARROW TRANSPLANTATION, 1998, 21 (12) : 1253 - 1262
  • [43] Transplantation of allogeneic CD34(+) peripheral blood stem cells in patients with advanced hematologic malignancy
    Bensinger, WI
    Buckner, CD
    ShannonDorcy, K
    Rowley, S
    Appelbaum, FR
    Benyunes, M
    Clift, R
    Martin, P
    Demirer, T
    Storb, R
    Lee, M
    Schiller, G
    BLOOD, 1996, 88 (11) : 4132 - 4138
  • [44] Additonal depletion of residual T cells from CD34 positively selected peripheral blood progenitor cells is necessary to achieve low T cell doses in some apheresis products.
    Collins, NH
    Bleau, SA
    Charles, CM
    Gemelli, P
    Smith, KM
    Alpdogan, O
    O'Reilly, RJ
    BLOOD, 2000, 96 (11) : 184A - 184A
  • [45] ENRICHMENT OF CD34(+) HEMATOPOIETIC PROGENITOR CELLS FROM NORMAL PERIPHERAL HUMAN BLOOD - COMPARISON OF DIFFERENT DEPLETION AND SELECTION PROCEDURES
    AOUSTIN, L
    BOUDINOT, P
    BATARD, P
    MONIER, MN
    DUPUY, C
    HATZFELD, J
    BOURIN, P
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 813 - 813
  • [46] T-cell depletion of peripheral blood progenitor cells (PBPC) by either CD34(+) selection and E-rosette depletion or sea agglutination and E-rosette depletion: Comparison of T-cell and hematopoietic cell progenitor recovery.
    Fernandez, JM
    Yan, Y
    Bleau, S
    Collins, NH
    OReilly, RJ
    BLOOD, 1995, 86 (10) : 2491 - 2491
  • [47] Successful Mobilization of Autologous Hematopoietic Peripheral Blood Stem Cells after Salvage Chemotherapy in Patients with Low CD34 Blood Cell Counts
    Holmberg, Leona A.
    Linenberger, Michael
    Connelly-Smith, Laura
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (11): : 754 - 759
  • [48] Positive selection of CD34+ peripheral blood progenitor cells for autograft in patients with breast cancer
    De Rosa, L
    Pandolfi, A
    Montuoro, A
    Amodeo, R
    Pescarollo, A
    Passa, AR
    Tocci, D
    De Laurenzi, A
    BONE MARROW TRANSPLANTATION, 1998, 21 : S58 - S58
  • [49] Results of Using Automated Clinimacs Prodigy for CD34 Selection from Mobilized Peripheral Blood Stem Cell Products
    Bateman, Caroline M.
    Antonenas, Vicki
    Yehson, Kenneth
    Tong, Daochen
    Hansra, Gurdip
    Clancy, Leighton Edward
    Shaw, Peter J.
    Micklethwaite, Kenneth P.
    Gottlieb, David
    BLOOD, 2017, 130
  • [50] RESULTS OF USING AUTOMATED CLINIMACS PRODIGY FOR CD34 SELECTION FROM MOBILIZED PERIPHERAL BLOOD STEM CELL PRODUCTS
    Antonenas, V.
    CYTOTHERAPY, 2018, 20 (05) : E4 - E4